ES2052755T3 - Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas. - Google Patents

Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas.

Info

Publication number
ES2052755T3
ES2052755T3 ES88401420T ES88401420T ES2052755T3 ES 2052755 T3 ES2052755 T3 ES 2052755T3 ES 88401420 T ES88401420 T ES 88401420T ES 88401420 T ES88401420 T ES 88401420T ES 2052755 T3 ES2052755 T3 ES 2052755T3
Authority
ES
Spain
Prior art keywords
composition
pct
skin
phases
liposomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88401420T
Other languages
English (en)
Inventor
Alain Meybeck
Marc Dumas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LVMH Recherche GIE
Original Assignee
LVMH Recherche GIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9351991&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2052755(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LVMH Recherche GIE filed Critical LVMH Recherche GIE
Application granted granted Critical
Publication of ES2052755T3 publication Critical patent/ES2052755T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

EL INVENTO TRATA DE UNA COMPOSICION A BASE DE FASES LAMINARES LIPIDICAS HIDRATADAS O DE LIPOSOMAS. ESTA COMPOSICION SE CARACTERIZA EN QUE DICHAS FASES LAMINARES LIPISICAS HIDRATADAS O DICHOS LIPOSOMAS CONTIENEN AL MENOS EN PARTE, UN EXTRACTO DE MORERA, ESPECIALMENTE MORUS ALBA L. O MORUS RUBRA O AL MENOS UNA SUBSTANCIA QUIMICA EN PARTICULAR KUWANONA. SEGUN UN MODO DE REALIZACION PREFERIDA, LAS FASES LAMINARES LIPISICAS HIDRATADAS CONTIENEN AL MENOS EN PARTE ACIDO KOJICO O SUS DERIVADOS, ESPECIALMENTE SUS SALES O ESTERES Y / O HIDROQUINONA. ESTA COMPOSICION ES UTIL PARA LA PREPARACION DE COMPUESTOS FARMACEUTICOS, ESPECIALMENTE DERMATOLOGICAS, DE ACTIVIDAD DEPIGMENTANTE O ANTI - INFLAMATORIA O COMPUESTOS COSMETICOS.
ES88401420T 1987-06-12 1988-06-10 Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas. Expired - Lifetime ES2052755T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8708235A FR2616328B1 (fr) 1987-06-12 1987-06-12 Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de murier, ou au moins une flavone, en particulier une kuwanone et composition pharmaceutique, notamment dermatologique, a activite depigmentante, ou anti-inflammatoire, ou cosmetique, l'incorporant

Publications (1)

Publication Number Publication Date
ES2052755T3 true ES2052755T3 (es) 1994-07-16

Family

ID=9351991

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88401420T Expired - Lifetime ES2052755T3 (es) 1987-06-12 1988-06-10 Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas.

Country Status (10)

Country Link
US (1) US5164182A (es)
EP (1) EP0296923B1 (es)
JP (1) JP2544198B2 (es)
KR (1) KR920009587B1 (es)
AT (1) ATE80291T1 (es)
DE (2) DE296923T1 (es)
ES (1) ES2052755T3 (es)
FR (1) FR2616328B1 (es)
GR (1) GR3006356T3 (es)
WO (1) WO1988009654A1 (es)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2650953B1 (fr) * 1989-08-17 1991-12-06 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant au moins un derive de labdane, ou un extrait de plante en contenant; composition cosmetique ou pharmaceutique, notamment dermatologique l'incorporant
US5653997A (en) * 1991-02-28 1997-08-05 Parfums Christian Dior Antiallergic cosmetic or pharmaceutical composition
FR2673530B1 (fr) * 1991-03-06 1995-05-19 Monique Moreau Extraits de feuilles de murier, antiradicalaires et antimalondialdehyde.
US5653983A (en) * 1991-07-19 1997-08-05 Lvmh Recherche Compositions for the pigmentation of the skin or of the hair containing an extract of Marrubium vulgare, the process for it's manufacture and it's
IL99291A (en) * 1991-08-23 1997-04-15 Fischer Pharma Ltd Cosmetic preparations
US5332575A (en) * 1991-10-03 1994-07-26 Parfums Christian Dior Method of targeting melanocytes with a compound containing a fucose residue
US6068834A (en) 1994-03-04 2000-05-30 The Procter & Gamble Company Skin lightening compositions
US5874463A (en) * 1994-10-24 1999-02-23 Ancira; Margaret Hydroxy-kojic acid skin peel
FR2736263B1 (fr) * 1995-07-07 1997-09-26 C3D Sarl Composition dermocosmetique depigmentante et son utilisation
FR2739853B1 (fr) * 1995-10-16 1999-03-26 Ferent Maurice Procede d'obtention d'une composition contenant des ceramides simples, et composition obtenue
US6183774B1 (en) 1996-01-31 2001-02-06 Collaborative Laboratories, Inc. Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts
US6071535A (en) * 1996-01-31 2000-06-06 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US5874105A (en) * 1996-01-31 1999-02-23 Collaborative Laboratories, Inc. Lipid vesicles formed with alkylammonium fatty acid salts
US5935572A (en) * 1997-01-10 1999-08-10 Collaborative Laboratories, Inc. Composition containing protease separate from glycosidase for removing nits in treating lice infestation
FR2764189B1 (fr) * 1997-06-09 1999-08-27 Coletica Utilisation de sulfites et metabisulfites, pour la fabrication de compositions cosmetiques ou pharmaceutiques, notamment en dermatologie, a effet inhibiteur de la melanogenese ou a activite depigmentante
KR100494643B1 (ko) * 1997-07-18 2005-09-14 주식회사 태평양 정제상백피추출물을함유하는외용제조성물
US5919436A (en) * 1997-09-25 1999-07-06 The Board Of Regents Of The University Of Oklahoma Method of lightening skin
US6110448A (en) * 1997-09-25 2000-08-29 The Board Of Regents Of The University Of Oklahoma Method for causing skin lightening
US5879665A (en) * 1997-09-25 1999-03-09 The Board Of Regents Of The University Of Oklahoma Composition for causing skin lightening
US5824327A (en) * 1998-04-06 1998-10-20 Whittemore; Jerry Kojic dipalmitate skin whitening comestic composition
GB9921238D0 (en) * 1999-09-09 1999-11-10 Boots Co Plc Skincare composition
US6261566B1 (en) * 1999-10-22 2001-07-17 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic compositions containing mulberry extract and retinoids
KR100444196B1 (ko) * 2001-06-26 2004-08-11 나드리화장품주식회사 나노리포좀으로 안정화된 약용식물 복합 추출액 함유화장료 조성물
KR100434898B1 (ko) * 2001-06-26 2004-06-07 나드리화장품주식회사 액정좀으로 안정화된 약용 식물 복합 추출액 함유 화장료조성물
AUPR686701A0 (en) * 2001-08-07 2001-08-30 Stramit Corporation Limited Improved metal section
WO2003015808A1 (en) * 2001-08-16 2003-02-27 Hnat Thomas M Method and composition for treatment of wounds and burns
FR2830754B1 (fr) * 2001-10-12 2004-01-30 Silab Sa Compositions cosmetiques issues de morus, procede d'extraction d'un principe actif et principe actif obtenu
KR100450827B1 (ko) * 2002-04-13 2004-10-01 홍영식품 주식회사 뽕잎성분을 함유하는 츄잉껌 및 그의 제조방법
KR20040005434A (ko) * 2002-07-10 2004-01-16 학교법인 경희대학교 신경세포 보호 활성을 갖는 오디의 조추출물을 함유한조성물
KR100512330B1 (ko) * 2002-08-13 2005-09-02 나드리화장품주식회사 나노리포좀으로 안정화된 바오밥나무 추출물을 함유하는피부 보습 화장료 조성물
KR100482694B1 (ko) * 2002-11-06 2005-04-14 주식회사 태평양 발모 촉진용 리포좀 베이스, 그를 포함한 발모 촉진용화장료 조성물 및 그를 이용한 생약 성분의 흡수율 향상방법
KR100513082B1 (ko) * 2002-11-27 2005-09-07 나드리화장품주식회사 세라마이드 및 식물복합추출액을 포함하는 세라리포좀함유 화장료 조성물
AU2005316833B2 (en) * 2004-12-17 2012-03-08 Bionovo, Inc. Estrogenic extracts of Morus alba and uses thereof
EP1824340A4 (en) * 2004-12-17 2009-08-05 Bionovo Inc PROCESS FOR USING EXTRACTS OF SPECIES OF THE GENUS EPIMEDIUM
EP1736142A1 (en) * 2005-02-03 2006-12-27 Omboon Luanratana Anti-photoaging composition comprising mulberry extract
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
KR100803925B1 (ko) * 2005-07-13 2008-02-15 주식회사 코리아나화장품 나노리포좀으로 안정화된 감초, 산수유, 백하수오 및 상백피 추출물을 포함하는 피부노화 방지용 화장료 조성물
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
KR20070089459A (ko) * 2006-02-28 2007-08-31 (주)아모레퍼시픽 콜레스테릴 헤미숙신네이트 기반의 나노 전달체로 포집된상백피 추출물을 유효 성분으로 함유하는 피부 미백용조성물
KR100864852B1 (ko) * 2007-04-30 2008-10-23 경희대학교 산학협력단 소수성이 개선된 상엽 추출물의 제조방법
US8337916B2 (en) 2007-06-01 2012-12-25 Laila Nutraceuticals Use of Aphanamixis polystacha extracts or fractions against 5-lipoxygenase mediated diseases
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
WO2009021196A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of ligustrum lucidum and uses thereof
JP2010539086A (ja) * 2007-09-07 2010-12-16 バイオノボ・インコーポレーテッド マメ科ファミリーのクズのエストロゲン性抽出物およびその使用
CA2698719A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of asparagus conchinchinensis (lour.) merr of the liliaceae family and uses thereof
WO2009033075A1 (en) 2007-09-07 2009-03-12 Bionovo. Inc. ESTROGENIC EXTRACTS OF Scuttelaria barbata D. DON OF THE LABIATAE FAMILY AND USES THEREOF
AU2008296072A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Astragalus membranaceus Fisch.Bge.Var.mongolicus Bge. of the Leguminosae Family and uses thereof
AU2008326429A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
CA2706330A1 (en) * 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
AU2008326431A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
AU2008326426A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Methods of detecting and treatment of cancers using scuttelaria barbata extract
JP2011516583A (ja) * 2008-04-14 2011-05-26 バイオノボ・インコーポレーテッド エストロゲン受容体β介在疾患の治療のためのカリコシン及びその類似物質
US20090304825A1 (en) * 2008-05-06 2009-12-10 Bionovo, Inc. Estrogenic extracts for use in treating vaginal and vulvar atrophy
JP2011523713A (ja) * 2008-06-05 2011-08-18 バイオノボ・インコーポレーテッド 植物組成物由来の多種類の生体活性物質の定量方法
AU2009255626A1 (en) * 2008-06-06 2009-12-10 Bionovo, Inc. Anthraquinones and analogs from Rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
BRPI0817954B8 (pt) * 2008-08-14 2021-05-25 Univ Federal Para uso do 5-hidroxi-2-hidroximetil-y-pirona como agente de ativação do macrófago no combate da leishmaniose cutânea
EP2340027A4 (en) * 2008-09-03 2012-04-04 Bionovo Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
WO2010077165A1 (en) * 2008-12-31 2010-07-08 Obschestvo S Ogranichennoi Otvetstvennostju Scientific Company Flamena Phospholipid emulsion containing dihydroquercetin, and method of producing thereof
JP2012525412A (ja) * 2009-04-28 2012-10-22 バイオノボ・インコーポレーテッド 脂肪蓄積を減少させ、体重減少を誘導する方法
FR3072025B1 (fr) 2017-10-06 2019-11-01 Plant Advanced Technologies Pat Extraits racinaires de plantes du genre morus et leurs utilisations
JP7330489B2 (ja) * 2019-05-14 2023-08-22 共栄化学工業株式会社 皮膚外用剤
EP4072513A1 (en) 2019-12-10 2022-10-19 Mary Kay, Inc. Herbal cosmetic composition for treating skin

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856934A (en) * 1970-06-24 1974-12-24 A Kligman Skin depigmentation
JPS5244375A (en) * 1975-10-06 1977-04-07 Nissan Diesel Motor Co Ltd Link mechanism
JPS5318739A (en) * 1976-08-03 1978-02-21 Sansho Seiyaku Kk Decolorant for external application
JPS56120612A (en) * 1980-02-27 1981-09-22 Kanebo Keshohin Kk Beautifying cosmetic
EP0088046B1 (de) * 1982-02-17 1987-12-09 Ciba-Geigy Ag Lipide in wässriger Phase
JPS59157009A (ja) * 1983-02-25 1984-09-06 Yakurigaku Chuo Kenkyusho:Kk メラニン生成抑制外用剤
FR2543437B1 (fr) * 1983-03-30 1987-07-10 Duraffourd Alain Composition pour regenerer le collagene du tissu conjonctif de la peau et son procede de preparation
JPS60152414A (ja) * 1984-01-23 1985-08-10 Pola Chem Ind Inc パツプ剤
JPS60202806A (ja) * 1984-03-26 1985-10-14 Sansho Seiyaku Kk 色白化粧料
JPS61271204A (ja) * 1985-05-27 1986-12-01 Shiseido Co Ltd リポソ−ム製剤
FR2582941B3 (fr) * 1985-06-11 1987-10-09 Moreau Lavaud Reine Composition cosmetique a base d'extraits de feuilles du murier

Also Published As

Publication number Publication date
KR890701090A (ko) 1989-12-19
DE296923T1 (de) 1989-08-03
KR920009587B1 (ko) 1992-10-21
JPH03501843A (ja) 1991-04-25
ATE80291T1 (de) 1992-09-15
EP0296923A1 (fr) 1988-12-28
JP2544198B2 (ja) 1996-10-16
DE3874428T2 (de) 1993-03-11
GR3006356T3 (es) 1993-06-21
DE3874428D1 (de) 1992-10-15
FR2616328A1 (fr) 1988-12-16
EP0296923B1 (fr) 1992-09-09
WO1988009654A1 (fr) 1988-12-15
FR2616328B1 (fr) 1990-03-02
US5164182A (en) 1992-11-17

Similar Documents

Publication Publication Date Title
ES2052755T3 (es) Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas.
FR2591105B1 (fr) Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
MY110734A (en) Improvements in or relating to dioic acids.
GR3020613T3 (en) Cosmetic and dermatological compositions containing an association of ceramides and linoleic acids, their preparation.
CA2044269A1 (fr) Compositions pharmaceutiques et cosmetiques depigmentantes a base d'acide cafeique
DE59803974D1 (de) Balneologische Badezusätze, insbesondere in Form einer Brausetablette, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2782269B1 (fr) Composition cosmetique et/ou dermatologique contenant de l'acide salicylique ou un derive d'acide salicylique et son utilisation
ES524032A0 (es) Procedimiento para la preparacion de composiciones farmaceuticas dermicas de accion prolongada y continua a base de acidos grasos esenciales
FR2627385B3 (fr) Composition notamment utile comme matiere de base pour la preparation de compositions pharmaceutiques, notamment dermatologiques et/ou cosmetiques
BR0009340B1 (pt) composiÇço adequada para uso na pele ou no cabelo, produto para aplicaÇço na pele ou no cabelo, mÉtodo para preparar uma composiÇço adequada para aplicaÇço na pele ou no cabelo, e, uso de uma composiÇço.
GR3005612T3 (es)
HU906284D0 (en) Process for the production of 24-homo-d-vitamin derivatives and medical preparations containing them as active agents
KR20060069472A (ko) 피부 미백 및 검버섯 치료를 위한 바이오틴 또는 바이오틴유도체의 용도
ES551021A0 (es) Un procedimiento para la preparacion de un compuesto de champu.
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
DE69806962T2 (de) FSNMU als entzündungshemmende Mittel in den oberflächen Geweben von Säugetieren
GB2004741A (en) Cosmetic and pharmaceutical compositions for the skin
ZA90966B (en) Oxidized diphenylheteroalkanes,the preparation and use thereof
ES2009714T3 (es) Procedimiento de preparacion de una composicion a base de fases laminares lipidicas hidratadas o de liposomas, preferentemente para la preparacion de composiciones cosmeticas o farmaceuticas.
AU611113B2 (en) Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds
EP0381057A3 (en) Chemical composition for external application
FR2757391B1 (fr) Utilisation d'un extrait de la plante terminalia, dans les domaines cosmetique et pharmaceutique, notamment dermatologique
ES2039661T3 (es) Procedimiento de preparacion de una composicion de principios activos para la preparacion de una composicion farmaceutica o cosmetica.
ES2006121A6 (es) Procedimiento para la preparacion de una composicion farmaceutica destinada al tratamiento de enfermedades cutaneas.
ATE258783T1 (de) Therapeutische und kosmetische mittel, ihre verwendung und herstellungsverfahren

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 296923

Country of ref document: ES